Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05918016Unknown

Ultrasonographic Prognostic Scale of Periventricular Hemorrhagic Infarction

Role: lead

NCT03411018Completed

Respiratory Management of Preterm Infants and Bronchopulmonary Dysplasia

Role: lead

NCT05023694Completed

Risk Related Assistance During Stabilization In Newborns At Birth

Role: lead

NCT02748720Not ApplicableCompleted

Respiratory Dynamics During Birth Stabilization in Preterm Infants Less Than 32+6/7 Weeks Gestation

Role: lead

All 4 trials loaded